Holen Sie sich die Stockscreener-App
291.68
3.77%
-11.44
Handel nachbörslich:
291.68
Schlusskurs vom Vortag:
$303.12
Offen:
$303
24-Stunden-Volumen:
612.20K
Relative Volume:
1.51
Marktkapitalisierung:
$11.23B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$34.55M
KGV:
339.16
EPS:
0.86
Netto-Cashflow:
$134.18M
1W Leistung:
+8.56%
1M Leistung:
+8.75%
6M Leistung:
+49.42%
1J Leistung:
+12.92%
1-Tages-Spanne:
$290.55
$304.11
1-Wochen-Bereich:
$264.81
$310.00
52-Wochen-Spanne:
$148.00
$310.00
Penumbra Inc Stock (PEN) Company Profile
Firmenname
Penumbra Inc
Sektor
Branche
Telefon
(510) 995-2486
Adresse
ONE PENUMBRA PLACE, ALAMEDA, CA
Vergleichen Sie PEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
291.68 | 11.23B | 1.16B | 34.55M | 134.18M | 0.86 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-21 | Eingeleitet | UBS | Buy |
| 2024-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Eingeleitet | Stifel | Buy |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-31 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-07-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-29 | Herabstufung | Needham | Buy → Hold |
| 2023-01-30 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-05 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-09 | Hochstufung | Needham | Hold → Buy |
| 2022-07-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-04-19 | Eingeleitet | Deutsche Bank | Buy |
| 2022-03-08 | Eingeleitet | Needham | Hold |
| 2021-09-16 | Eingeleitet | Truist | Buy |
| 2021-06-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2020-09-29 | Eingeleitet | BTIG Research | Buy |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-06-13 | Bestätigt | BofA/Merrill | Buy |
| 2019-05-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Eingeleitet | William Blair | Outperform |
| 2018-10-29 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-10-08 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-02-21 | Eingeleitet | William Blair | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-13 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Penumbra Inc Aktie (PEN) Neueste Nachrichten
Penumbra, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
Penumbra Inc. Faces Financial Peril Amid Rising Customer Payment Defaults - TipRanks
Penumbra price target raised to $320 from $305 at UBS - TipRanks
Penumbra Announces Don Kassing Will Retire From Board Of Directors -February 21, 2025 at 05:50 pm EST - Marketscreener.com
Penumbra Announces Board Transition with Kassing’s Retirement - TipRanks
Leadership Shift at Penumbra: How Will 17-Year Board Veteran's Exit Shape Corporate Governance? - StockTitan
Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion - MSN
Neuro-interventional Devices Market Growth in Future Scope - openPR
Penumbra (PEN) Upgraded to Buy: Here's Why - Yahoo Finance
Why Penumbra (PEN) Stock Is Trading Up Today - MSN
Here's What Key Metrics Tell Us About Penumbra (PEN) Q4 Earnings - MSN
Penumbra Inc. Earnings Call Reveals Strong U.S. Growth - TipRanks
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook - Benzinga
Why Penumbra (PEN) Stock Is Trading Up Today By Stock Story - Investing.com Canada
UBS raises Penumbra stock price target to $320, keeps buy rating - Investing.com
Penumbra stock hits 52-week high, reaches $296.1 - Investing.com India
Penumbra stock hits 52-week high, reaches $296.1 By Investing.com - Investing.com Nigeria
Truist Securities Raises Price Target on Penumbra to $325 From $285, Keeps Buy Rating - Marketscreener.com
Penumbra, Inc. (NYSE:PEN) Q4 2024 Earnings Call Transcript - Insider Monkey
Penumbra price target raised to $340 from $323 at Canaccord - TipRanks
Compass, Penumbra, Bumble - TradingView
Deutsche Bank Adjusts Penumbra Price Target to $326 From $241, Maintains Buy Rating - Marketscreener.com
Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises - Yahoo Finance
Penumbra price target raised to $330 from $250 at Piper Sandler - TipRanks
Penumbra Inc earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Axsome Therapeutics, Penumbra, Republic Services - TradingView
Penumbra Inc (PEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid International ... - Yahoo Finance
Penumbra Inc (PEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid International ... By GuruFocus - Investing.com Canada
Penumbra: Q4 Earnings Snapshot - The Advocate
Penumbra, Inc. Reports Strong 2024 Financial Performance - TipRanks
Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates - MSN
Penumbra’s Impressive Revenue Sparks Stock Reactions - TipRanks
Earnings call transcript: Penumbra Q4 2024 beats expectations, stock surges - Investing.com
Penumbra Inc Q4 2024 Earnings: Revenue Surpasses Estimates at $3 - GuruFocus.com
Earnings call transcript: Penumbra Q4 2024 beats expectations, stock surges By Investing.com - Investing.com UK
Penumbra Inc SEC 10-K Report - TradingView
Penumbra's Q4 earnings beat lifts stock 3.2% By Investing.com - Investing.com Canada
Penumbra’s Q4 earnings beat lifts stock 3.2% By Investing.com - Investing.com Nigeria
Penumbra's Q4 earnings beat lifts stock 3.2% - Investing.com
Earnings Flash (PEN) PENUMBRA INC. Posts Q4 Revenue $315.5M, vs. FactSet Est of $311.4M - Marketscreener.com
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates - Yahoo Finance
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - PR Newswire
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Penumbra Inc. Set to Announce Earnings Amidst Market InterestNews and Statistics - IndexBox, Inc.
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings By Stock Story - Investing.com Canada
PENUMBRA Earnings Preview: Recent $PEN Insider Trading, Hedge Fund Activity, and More - Nasdaq
Allspring Global Investments Holdings LLC Grows Stock Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra, Inc. (NYSE:PEN) Short Interest Update - MarketBeat
Penumbra (PEN) to Release Quarterly Earnings on Tuesday - MarketBeat
WCM Investment Management LLC Makes New Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks In Q3 - Yahoo Finance
Finanzdaten der Penumbra Inc-Aktie (PEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):